Somatic Mutations in Brazilian Patients with Paroxysmal Nocturnal Hemoglobinuria: a Comprehensive Analysis

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2025 Mar 11

PMID 40066167

Authors

Patricia Eiko Yamakawa

Caio Perez Gomes

Agatha Ribeiro Mendes

Caio Cesar Justino de Oliveira

Florencio Porto Freitas

Fabiana Bettoni

Ernande Xavier Dos Santos

Vinicius Campos de Molla

Matheus Vescovi Goncalves

Jessica Branquinho

Beatriz Ribeiro Nogueira

Joao Bosco Pesquero

Celso Arrais-Rodrigues

Affiliations

Soon will be listed here.

Abstract

Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal hematopoietic stem cell disease characterized by acquired abnormalities in the phosphatidylinositol glycan class A () gene.

Methods: This study analyzed gene using polymerase chain reaction (PCR) followed by Sanger sequencing of 31 Brazilian patients with PNH, including 23 with classical PNH and 8 with subclinical PNH (aplastic anemia and a PNH clone).

Results: A diverse spectrum of acquired variants was identified, encompassing insertions, deletions, and single-base substitutions. The majority of variants identified (17 out of 29) were deemed likely pathogenic for paroxysmal nocturnal hemoglobinuria (PNH). Six variants have undetermined significance (VUS) and six variants are probably benign. Somatic variants exhibited variability in type and location among the patients, with a predominance of small deletions and simple base changes. Notably, 41% of the variants were frameshift and 35% were missense. Among the 23 patients with hemolytic PNH, 19 had at least one detectable pathogenic variant. Subclinical PNH cases were characterized solely by polymorphisms.

Conclusion: In conclusion, the somatic variants in Brazilian PNH patients displayed variability in both site distribution and type. Contrary to mutational hotspots observed in previous studies, none were identified in this cohort. No specific correlation between the clinical characteristics of hemolytic PNH patients and their variants was found, likely due to the extensive variety of mutations.

References

Chen F, Hu S, Ruan J, Chen M, Han B . Mutational landscape and its clinical significance in paroxysmal nocturnal hemoglobinuria. Blood Cancer J. 2021; 11(3):58. PMC: 7966366. DOI: 10.1038/s41408-021-00451-1. View

Boccuni P, Del Vecchio L, Di Noto R, Rotoli B . Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria. Crit Rev Oncol Hematol. 2000; 33(1):25-43. DOI: 10.1016/s1040-8428(99)00052-9. View

Miyata T, Takeda J, Iida Y, Yamada N, Inoue N, Takahashi M . The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science. 1993; 259(5099):1318-20. DOI: 10.1126/science.7680492. View

Borowitz M, Craig F, DiGiuseppe J, Illingworth A, Rosse W, Sutherland D . Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom. 2010; 78(4):211-30. DOI: 10.1002/cyto.b.20525. View

Sugimori C, Padron E, Caceres G, Shain K, Sokol L, Zhang L . Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood Cancer J. 2012; 2(3):e63. PMC: 3317526. DOI: 10.1038/bcj.2012.7. View

Nafa K, Mason P, Hillmen P, Luzzatto L, Bessler M . Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood. 1995; 86(12):4650-5. View

Murakami Y, Inoue N, Shichishima T, Ohta R, Noji H, Maeda Y . Deregulated expression of HMGA2 is implicated in clonal expansion of PIGA deficient cells in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2011; 156(3):383-7. DOI: 10.1111/j.1365-2141.2011.08914.x. View

Hu R, Mukhina G, Piantadosi S, Barber J, Jones R, Brodsky R . PIG-A mutations in normal hematopoiesis. Blood. 2005; 105(10):3848-54. PMC: 1895084. DOI: 10.1182/blood-2004-04-1472. View

Mortazavi Y, Merk B, McIntosh J, Marsh J, Schrezenmeier H, Rutherford T . The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot. Blood. 2002; 101(7):2833-41. DOI: 10.1182/blood-2002-07-2095. View

10.

Clemente M, Przychodzen B, Hirsch C, Nagata Y, Bat T, Wlodarski M . Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria. Leukemia. 2018; 32(11):2507-2511. PMC: 8694093. DOI: 10.1038/s41375-018-0138-5. View

11.

Franco De Carvalho R, Arruda V, Saad S, Costa F . Detection of somatic mutations of the PIG-A gene in Brazilian patients with paroxysmal nocturnal hemoglobinuria. Braz J Med Biol Res. 2001; 34(6):763-6. DOI: 10.1590/s0100-879x2001000600010. View

12.

Savage W, Barber J, Mukhina G, Hu R, Chen G, Matsui W . Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH. Exp Hematol. 2008; 37(1):42-51. PMC: 2628761. DOI: 10.1016/j.exphem.2008.09.002. View

13.

Karczewski K, Francioli L, Tiao G, Cummings B, Alfoldi J, Wang Q . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809):434-443. PMC: 7334197. DOI: 10.1038/s41586-020-2308-7. View

14.

Araten D, Bessler M, McKenzie S, Castro-Malaspina H, Childs B, Boulad F . Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia. 2002; 16(11):2243-8. DOI: 10.1038/sj.leu.2402694. View

15.

Pramoonjago P, Pakdeesuwan K, Siripanyaphinyo U, Chinprasertsuk S, Kinoshita T, Wanachiwanawin W . Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1999; 105(2):497-504. View

16.

Li L, Wang H, Liu H, Liu Z, Li L, Ding K . Gene mutations associated with thrombosis detected by whole-exome sequencing in paroxysmal nocturnal hemoglobinuria. Int J Lab Hematol. 2019; 41(3):424-432. DOI: 10.1111/ijlh.13018. View

17.

Iida Y, Takeda J, Miyata T, Inoue N, Nishimura J, Kitani T . Characterization of genomic PIG-A gene: a gene for glycosylphosphatidylinositol-anchor biosynthesis and paroxysmal nocturnal hemoglobinuria. Blood. 1994; 83(11):3126-31. View

18.

Shen W, Clemente M, Hosono N, Yoshida K, Przychodzen B, Yoshizato T . Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria. J Clin Invest. 2014; 124(10):4529-38. PMC: 4191017. DOI: 10.1172/JCI74747. View

19.

Parker C . Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria. Hematology Am Soc Hematol Educ Program. 2016; 2016(1):208-216. PMC: 6142517. DOI: 10.1182/asheducation-2016.1.208. View

20.

Nafa K, Bessler M, Castro-Malaspina H, Jhanwar S, Luzzatto L . The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. Blood Cells Mol Dis. 1998; 24(3):370-84. DOI: 10.1006/bcmd.1998.0203. View